Abstract-We have previously reported that the expression of Angiotensin II (Ang II) type 1 receptors (AT1R) was increased in the rostral ventrolateral medulla (RVLM) of rabbits with chronic heart failure (CHF) and in the RVLM of normal rabbits infused with intracerebroventricular (ICV) Ang II. The present study investigated whether oxidant stress plays a role in Ang II-induced AT1R upregulation and its relationship to the transcription factor activator protein 1 (AP1) in CHF rabbits and in the CATHa neuronal cell line. Key Words: angiotensin ii Ⅲ antioxidant enzymes Ⅲ brain Ⅲ c-jun Ⅲ c-Jun NH2-terminal kinase A ngiotensin II (Ang II), the principle mediator of the renin-angiotensin system, plays a pivotal role in cardiovascular and renal homeostasis. Most of the physiological and pathophysiological effects of Ang II are mediated by the Angiotensin II type 1 receptor (AT1R). The activation of the renin-angiotensin system and the sympathetic nervous system in chronic heart failure (CHF) are critical factors that contribute to the development and progression of CHF in patients. 1,2 Evidence also demonstrates that AT1R blockers, when added to conventional treatment for patients with CHF, are associated with a reduction in morbidity and mortality as well as an improvement in quality of life. 3 Currently, blockade of the renin-angiotensin system has become the primary treatment for patients with CHF. Therefore, a comprehensive understanding of the regulation of the AT1R is necessary for developing new therapies to target this receptor in the setting of CHF.The role of reactive oxygen species (ROS) in the cardiovascular system has been investigated extensively over the past decade. 4 It has been reported that, in the rostral ventrolateral medulla (RVLM), the levels of ROS are elevated in stroke-prone spontaneously hypertensive rats. Scavenging superoxide anion (O 2•Ϫ ) in the RVLM reduces both sympathetic nerve activity and blood pressure. 5 Similar evidence has been provided for rabbits with CHF. 6 Ang II induces a rapid and transient increase in ROS in a wide variety of cell types. 7 Ang II-induced ROS-formation is attenuated by the NADPH oxidase inhibitor diphenyleneiodonium chloride (DPI), suggesting that it is mediated through NADPH Oxidase. 7 In addition, Ang II-induced ROS-formation can also be blocked by losartan, 8 suggesting that AT1R and its downstream pathway are involved.However, the downstream targets of ROS have remained largely unexplored, at least for the regulation of the AT1R. Extracellular administration of nonlethal concentrations of H 2 O 2 has been demonstrated to activate mitogen-activated protein kinase (MAPK) as well as the c-Jun amino-terminal kinase (JNK). 9 Endogenous ROS induced by Ang II has also been shown to activate stress activated protein kinase (SAPK), which can be inhibited by treating cells with Original